<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for MK-677</title><link>https://peptidescanner.com/peptides/mk-677/</link><description>Versioned, source-linked PeptideScanner evidence objects for MK-677. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/mk-677.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00395291</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00395291-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00395291-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#clinicaltrials-gov-nct00395291-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-02-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05364684</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05364684-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05364684-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#clinicaltrials-gov-nct05364684-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-01-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31964466-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31964466-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-31964466-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-11-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34542924-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34542924-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-34542924-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-01-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34737341-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34737341-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-34737341-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-10-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36303408-mk-677/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36303408-mk-677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mk-677.json#pubmed-pmid-36303408-mk-677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
